Pathological and WB analysis showed that the tumors in combination group exhibited apparent inhibition of CDK4/6 activity as the phosphorylation of RB (pRB, Ser807/811) in the combination group was efficiently reduced (Fig. 6H and I), suggesting an evident cell cycle arrest and tumor proliferation restriction. This evidence concerns the gene CDK4 and neoplasm.